Compass

HEALTH, MARGINALLY CHEAPER

02/10/19 -"The Health (ex Pharma) sector has lost ground over the last month but this reflects more a risk-on market context than a genuine sell-off in this expensive territory. Health stocks have been losing ..."

PDF page sample
Pages
49
Language
English
Published on
02/10/19
Download
You may also be interested by these reports :
13/11/25
Flutter’s Q3 2025 results were below market expectations. While iGaming and international diversification provided resilience, revenue fell short of ...
05/11/25
At the beginning of spring 2024, our optimism for FDJ United (BUY; France) was underpinned by an attractive home market, which was further ...
05/11/25
JDW’s Q1 FY25/26 results beat expectations, with like-for-like sales up 3.7% yoy, led by strong bar and gaming revenues. We believe that growth ...
31/10/25
Meliá delivered peer-outperforming and consensus-beating summer results, primarily supported by its leading exposure to the resilient Spanish market. ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO